|
SE9904723D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
SE9904724D0
(sv)
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission I
|
|
USRE46117E1
(en)
|
1999-12-22 |
2016-08-23 |
Teva Pharmaceuticals International Gmbh |
Modulators of dopamine neurotransmission
|
|
WO2002059107A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
US7169777B2
(en)
|
2001-01-23 |
2007-01-30 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
WO2002059117A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
|
|
JP2004532838A
(ja)
|
2001-03-02 |
2004-10-28 |
ブリストル−マイヤーズ スクイブ カンパニー |
メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
|
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US6977264B2
(en)
*
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
CA2462200A1
(en)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
US7354923B2
(en)
|
2001-08-10 |
2008-04-08 |
Palatin Technologies, Inc. |
Piperazine melanocortin-specific compounds
|
|
US7456184B2
(en)
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
UA81749C2
(uk)
*
|
2001-10-04 |
2008-02-11 |
Х. Луннбек А/С |
Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
|
|
WO2003061660A1
(en)
*
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
|
JP2005534632A
(ja)
*
|
2002-05-10 |
2005-11-17 |
ニューロクライン バイオサイエンセズ， インコーポレイテッド |
メラノコルチンレセプターリガンドとしての置換ピペラジン
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
TW200504033A
(en)
*
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
WO2004081643A1
(en)
*
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2004078717A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
WO2004081005A1
(en)
*
|
2003-03-07 |
2004-09-23 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
CA2517291C
(en)
|
2003-03-19 |
2012-05-08 |
Exelixis, Inc. |
Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
|
|
EP1460069A1
(en)
*
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
|
EP1468999A1
(en)
*
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
CA2519939A1
(en)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
|
EP1644347A1
(en)
*
|
2003-06-20 |
2006-04-12 |
Arena Pharmaceuticals, Inc. |
N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT sb 2C /sb RECEPTOR ASSOCIATED DISEASES
|
|
AU2004274309B2
(en)
|
2003-09-22 |
2010-04-08 |
Msd K.K. |
Novel piperidine derivative
|
|
US20050192286A1
(en)
*
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050119252A1
(en)
*
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
EP1538159A1
(en)
*
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Substituted N-benzyl-lactam derivatives as melanocortin-4 receptor agonists
|
|
CN100526301C
(zh)
*
|
2003-12-26 |
2009-08-12 |
卫材R&D管理有限公司 |
1,2-二(环式基)取代苯化合物
|
|
US7410971B2
(en)
|
2003-12-26 |
2008-08-12 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic)substituted benzene compounds
|
|
MY140489A
(en)
*
|
2003-12-26 |
2009-12-31 |
Eisai R&D Man Co Ltd |
1,2-di (cyclic) substituted benzene compounds
|
|
US20060276465A1
(en)
*
|
2003-12-26 |
2006-12-07 |
Eisai R&D Management Co., Ltd. |
1,2-di(cyclic) substituted benzene compounds
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
SE0401465D0
(sv)
|
2004-06-08 |
2004-06-08 |
Carlsson A Research Ab |
New substituted piperdines as modulators of dopamine neurotransmission
|
|
DE602005021641D1
(de)
|
2004-06-08 |
2010-07-15 |
Nsab, Filial Af Neurosearch Sweden Ab |
Neue disubstituierte phenylpiperidine und piperazine als modulatoren der dopamin-neurotransmission
|
|
RU2366654C2
(ru)
*
|
2004-06-08 |
2009-09-10 |
ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ |
Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии
|
|
US7851629B2
(en)
|
2004-06-08 |
2010-12-14 |
Nsab, Filial Af Neurosearch Sweden Ab, Sverige |
Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
|
JP2008501749A
(ja)
*
|
2004-06-08 |
2008-01-24 |
ニューロサーチ スウェーデン アクチボラゲット |
ドーパミン及びセロトニン神経伝達のモジュレーターとしての新規なジ置換フェニルピペリジン
|
|
CA2584831C
(en)
|
2004-10-13 |
2013-09-17 |
Neurosearch Sweden Ab |
Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine
|
|
CA2594987A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Shionogi & Co., Ltd. |
Therapeutic agent for constipation
|
|
EP1832580A4
(en)
|
2004-12-20 |
2009-03-11 |
Eisai R&D Man Co Ltd |
1-CYCLOPROPYLMETHYL-4-Ý2- (3,3,5,5) -TETRAMETHYLCYCLOHEXYL) PHENYL PIPERAZINE CRYSTAL AND SALT
|
|
CA2609388C
(en)
|
2005-05-30 |
2013-08-06 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
MY144974A
(en)
*
|
2005-06-14 |
2011-11-30 |
Eisai R&D Man Co Ltd |
1,2-di(cyclic) substituted benzene derivatives
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
EP1921065B1
(en)
|
2005-08-24 |
2010-10-20 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
BRPI0616463A2
(pt)
|
2005-09-29 |
2011-06-21 |
Merck & Co Inc |
composto, composição farmacêutica, e, uso de um composto
|
|
SE529246C2
(sv)
|
2005-10-13 |
2007-06-12 |
Neurosearch Sweden Ab |
Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
|
|
EP1940401B1
(en)
|
2005-10-18 |
2012-07-11 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
WO2007048027A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
US8158791B2
(en)
|
2005-11-10 |
2012-04-17 |
Msd K.K. |
Aza-substituted spiro derivatives
|
|
US7601844B2
(en)
*
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
|
WO2007096186A1
(en)
*
|
2006-02-23 |
2007-08-30 |
Santhera Pharmaceuticals (Schweiz) Ag |
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
DK2035369T3
(da)
|
2006-07-05 |
2014-10-06 |
Fibrotech Therapeutics Pty Ltd |
Terapeutiske
|
|
JP5489333B2
(ja)
|
2006-09-22 |
2014-05-14 |
メルク・シャープ・アンド・ドーム・コーポレーション |
脂肪酸合成阻害剤を用いた治療の方法
|
|
AU2007301126A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
CA2682727C
(en)
|
2007-04-02 |
2016-03-22 |
Banyu Pharmaceutical Co., Ltd. |
Indoledione derivative
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2019100A1
(en)
*
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
EP2020405A1
(en)
*
|
2007-07-30 |
2009-02-04 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
|
EP2272841A1
(en)
|
2008-03-28 |
2011-01-12 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
TWI433838B
(zh)
|
2008-06-25 |
2014-04-11 |
必治妥美雅史谷比公司 |
作為趨化因子受體活性調節劑之六氫吡啶衍生物
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
５員－５員又は５員－６員縮環シクロアルキルアミン誘導体
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
UA99555C2
(en)
|
2008-11-12 |
2012-08-27 |
Элджи Лайф Саенсез Лтд. |
Melanocortin receptor agonists
|
|
JP5514831B2
(ja)
|
2008-11-17 |
2014-06-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病の治療のための置換二環式アミン
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
EP2491030B1
(en)
|
2009-10-22 |
2015-07-15 |
Fibrotech Therapeutics PTY LTD |
Fused ring analogues of anti-fibrotic agents
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
EP2563764B1
(en)
|
2010-04-26 |
2015-02-25 |
Merck Sharp & Dohme Corp. |
Novel spiropiperidine prolylcarboxypeptidase inhibitors
|
|
US9365539B2
(en)
|
2010-05-11 |
2016-06-14 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
|
US9006268B2
(en)
|
2010-06-11 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
|
US8642622B2
(en)
|
2010-06-16 |
2014-02-04 |
Bristol-Myers Squibb Company |
Piperidinyl compound as a modulator of chemokine receptor activity
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012100342A1
(en)
|
2011-01-27 |
2012-08-02 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
|
MX347209B
(es)
|
2011-12-08 |
2017-04-19 |
Teva Pharmaceuticals Int Gmbh |
La sal de bromhidrato de pridopidina.
|
|
US9266876B2
(en)
|
2012-02-02 |
2016-02-23 |
Actelion Pharmaceuticals Ltd. |
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
|
|
HK1206297A1
(en)
|
2012-04-04 |
2016-01-08 |
Teva Pharmaceuticals International Gmbh |
Pharmaceutical compositions for combination therapy
|
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
EP2746259A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
EP2746260A1
(en)
|
2012-12-21 |
2014-06-25 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds
|
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
EP3006454B1
(en)
|
2013-06-05 |
2021-01-13 |
Shanghai Lumosa Therapeutics Co., Ltd. |
New compounds having triple activities of thrombolysis, antithrombotic and radical scavenging, and synthesis, nano-structure and use thereof
|
|
EA030067B1
(ru)
|
2013-07-22 |
2018-06-29 |
Идорсиа Фармасьютиклз Лтд |
Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
KR102431436B1
(ko)
|
2014-08-29 |
2022-08-10 |
테스 파마 에스.알.엘. |
α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
JP6337218B2
(ja)
|
2015-01-15 |
2018-06-06 |
イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
Ｃｘｃｒ３受容体調節剤としてのヒドロキシアルキル−ピペラジン誘導体
|
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
|
CN105461635B
(zh)
*
|
2015-11-18 |
2018-06-08 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
CN105348204B
(zh)
*
|
2015-11-18 |
2018-09-14 |
乳源瑶族自治县大众药品贸易有限公司 |
1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途
|
|
CN105294554B
(zh)
*
|
2015-11-18 |
2017-11-07 |
乳源瑶族自治县大众药品贸易有限公司 |
苯基哌嗪衍生物及其使用方法和用途
|
|
AR109950A1
(es)
|
2016-10-14 |
2019-02-06 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
CA3052036A1
(en)
|
2017-02-03 |
2018-08-09 |
Certa Therapeutics Pty Ltd. |
Anti-fibrotic compounds
|
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
EP3821947A1
(en)
*
|
2019-11-13 |
2021-05-19 |
Libra Therapeutics, Inc. |
Heterocyclic trpml1 agonists
|
|
TW202136219A
(zh)
*
|
2019-12-19 |
2021-10-01 |
美商卡司馬療法公司 |
Trpml調節劑
|
|
AR129265A1
(es)
|
2022-05-12 |
2024-08-07 |
Syngenta Crop Protection Ag |
Compuestos de alcoxi-heteroaril-carboxamida o tioamida
|
|
WO2024033374A1
(en)
|
2022-08-11 |
2024-02-15 |
Syngenta Crop Protection Ag |
Novel arylcarboxamide or arylthioamide compounds
|
|
WO2024089216A1
(en)
|
2022-10-27 |
2024-05-02 |
Syngenta Crop Protection Ag |
Novel sulfur-containing heteroaryl carboxamide compounds
|
|
CN120476107A
(zh)
|
2022-12-15 |
2025-08-12 |
先正达农作物保护股份公司 |
可用作杀有害生物剂的新型的二环-甲酰胺化合物
|
|
AR131541A1
(es)
|
2023-01-07 |
2025-04-09 |
Syngenta Crop Protection Ag |
Compuestos de carboxamida novedosos
|
|
WO2025032129A1
(en)
|
2023-08-08 |
2025-02-13 |
Syngenta Crop Protection Ag |
Novel aminoindane and aminotetraline compounds
|
|
WO2025104032A1
(en)
|
2023-11-14 |
2025-05-22 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2025109114A1
(en)
|
2023-11-24 |
2025-05-30 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
WO2025149637A1
(en)
|
2024-01-12 |
2025-07-17 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|
|
PY2501648A
(es)
|
2024-01-12 |
2025-10-31 |
Syngenta Crop Protection Ag |
Nuevos compuestos de carboxamida
|
|
WO2026008750A1
(en)
|
2024-07-05 |
2026-01-08 |
Syngenta Crop Protection Ag |
Novel carboxamide compounds
|